Funds Pile Into Torrent, Biocon, Diamond Power in July
Get the Finance newsletter
Daily finance — markets, central banks, M&A, the prints that move money. Free.
- Torrent Pharmaceuticals topped large-cap mutual fund purchases in July 2026 with ₹7,014 crore in fresh buying, narrowly ahead of Adani Enterprises at ₹6,743 crore.
- Axis Bank and Kotak Mahindra Bank anchored banking-sector large-cap buying at ₹3,522 crore and ₹3,262 crore respectively, with banking and financial services leading the large-cap segment overall.
- Biocon led mid-cap purchases at ₹3,234 crore, followed by PB Fintech at ₹2,875 crore; consumer-facing Lenskart Solutions and Swiggy each drew over ₹1,000 crore, while Meesho saw ₹860 crore.
- Diamond Power Infrastructure topped small-cap buying at ₹1,605 crore, followed by Jupiter Life Line Hospitals at ₹1,126 crore and Sterlite Technologies at ₹1,108 crore.
- The buying cut across pharmaceuticals, banking, technology, healthcare, and financial services, per Value Research data compiled from July vs. June 2026 portfolio disclosures (passive funds excluded, valued at month-end prices).
Why it matters: Indian mutual funds concentrated ₹7,014 crore in Torrent Pharmaceuticals and channeled fresh capital into IPO-era consumer brands (Lenskart, Swiggy, Meesho) and bank stocks (Axis, Kotak) in July 2026. The breadth across large-, mid-, and small-cap segments signals active managers were rotating across risk profiles rather than picking one theme.
Ask SkimNews
